CAMP4 Total Liab vs Other Stockholder Equity Analysis

CAMP Stock

USD 4.91 1.16 30.93%

CAMP4 THERAPEUTICS financial indicator trend analysis is way more than just evaluating CAMP4 THERAPEUTICS prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CAMP4 THERAPEUTICS is a good investment. Please check the relationship between CAMP4 THERAPEUTICS Total Liab and its Other Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Total Liab vs Other Stockholder Equity

Total Liab vs Other Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CAMP4 THERAPEUTICS Total Liab account and Other Stockholder Equity. At this time, the significance of the direction appears to have strong relationship.

The correlation between CAMP4 THERAPEUTICS's Total Liab and Other Stockholder Equity is 0.74. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of CAMP4 THERAPEUTICS PORATION, assuming nothing else is changed. The correlation between historical values of CAMP4 THERAPEUTICS's Total Liab and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of CAMP4 THERAPEUTICS PORATION are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Total Liab i.e., CAMP4 THERAPEUTICS's Total Liab and Other Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.74

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Other Stockholder Equity

Most indicators from CAMP4 THERAPEUTICS's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CAMP4 THERAPEUTICS current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

At this time, CAMP4 THERAPEUTICS's Selling General Administrative is relatively stable compared to the past year. As of 03/02/2025, Enterprise Value Over EBITDA is likely to grow to 535.90, while Issuance Of Capital Stock is likely to drop 0.00.

	2022	2024	2025 (projected)
Interest Expense	6.3M	4.2M	8.3M
Depreciation And Amortization	21.8M	19.6M	17.8M

Interest Expense Depreciation And Amortization

CAMP4 THERAPEUTICS fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Common Stock Shares Outstanding
Total Assets		-0.5	-0.24	1.0	0.99	0.98	0.89	-0.78	0.73	0.79	0.89	1.0	0.88	0.86	-0.67	0.89	0.92	0.76	0.94	0.83	0.95	1.0	0.8	0.87	-0.89	-0.89
Short Long Term Debt Total	-0.5		0.0	-0.49	-0.49	-0.39	-0.35	0.73	0.01	-0.54	-0.45	-0.51	-0.6	-0.44	0.93	-0.27	-0.55	0.01	-0.62	-0.81	-0.53	-0.5	-0.06	-0.3	0.62	0.7
Other Current Liab	-0.24	0.0		-0.31	-0.09	-0.11	0.1	-0.23	0.21	-0.71	0.19	-0.26	-0.58	0.23	-0.14	-0.07	-0.55	0.03	-0.46	0.13	-0.4	-0.2	0.11	0.15	0.05	0.16
Total Current Liabilities	1.0	-0.49	-0.31		0.97	0.97	0.87	-0.75	0.7	0.83	0.85	1.0	0.9	0.82	-0.63	0.87	0.95	0.75	0.95	0.8	0.96	0.99	0.77	0.84	-0.88	-0.89
Total Stockholder Equity	0.99	-0.49	-0.09	0.97		0.99	0.92	-0.84	0.8	0.7	0.94	0.98	0.81	0.92	-0.69	0.89	0.86	0.79	0.88	0.86	0.92	0.99	0.84	0.92	-0.9	-0.88
Property Plant And Equipment Net	0.98	-0.39	-0.11	0.97	0.99		0.95	-0.79	0.85	0.66	0.94	0.97	0.77	0.92	-0.61	0.94	0.85	0.87	0.85	0.8	0.9	0.98	0.9	0.95	-0.9	-0.87
Current Deferred Revenue	0.89	-0.35	0.1	0.87	0.92	0.95		-0.8	0.92	0.47	0.96	0.87	0.58	0.95	-0.57	0.92	0.7	0.91	0.7	0.74	0.79	0.91	0.92	0.98	-0.9	-0.84
Net Debt	-0.78	0.73	-0.23	-0.75	-0.84	-0.79	-0.8		-0.63	-0.45	-0.91	-0.77	-0.58	-0.92	0.92	-0.62	-0.66	-0.56	-0.68	-0.9	-0.77	-0.8	-0.65	-0.82	0.85	0.83
Retained Earnings	0.73	0.01	0.21	0.7	0.8	0.85	0.92	-0.63		0.22	0.88	0.71	0.34	0.88	-0.3	0.85	0.5	0.97	0.46	0.51	0.62	0.76	0.98	0.95	-0.71	-0.6
Accounts Payable	0.79	-0.54	-0.71	0.83	0.7	0.66	0.47	-0.45	0.22		0.45	0.81	0.98	0.41	-0.51	0.54	0.94	0.32	0.95	0.59	0.85	0.77	0.32	0.41	-0.61	-0.7
Cash	0.89	-0.45	0.19	0.85	0.94	0.94	0.96	-0.91	0.88	0.45		0.87	0.58	1.0	-0.71	0.84	0.69	0.83	0.7	0.83	0.8	0.9	0.89	0.98	-0.89	-0.82
Non Current Assets Total	1.0	-0.51	-0.26	1.0	0.98	0.97	0.87	-0.77	0.71	0.81	0.87		0.89	0.85	-0.66	0.88	0.93	0.75	0.94	0.83	0.95	1.0	0.78	0.86	-0.89	-0.89
Non Currrent Assets Other	0.88	-0.6	-0.58	0.9	0.81	0.77	0.58	-0.58	0.34	0.98	0.58	0.89		0.55	-0.62	0.64	0.96	0.41	0.99	0.72	0.9	0.86	0.44	0.54	-0.71	-0.78
Cash And Short Term Investments	0.86	-0.44	0.23	0.82	0.92	0.92	0.95	-0.92	0.88	0.41	1.0	0.85	0.55		-0.71	0.82	0.66	0.83	0.66	0.81	0.79	0.88	0.89	0.98	-0.87	-0.81
Net Receivables	-0.67	0.93	-0.14	-0.63	-0.69	-0.61	-0.57	0.92	-0.3	-0.51	-0.71	-0.66	-0.62	-0.71		-0.45	-0.62	-0.25	-0.67	-0.92	-0.67	-0.67	-0.36	-0.57	0.76	0.79
Good Will	0.89	-0.27	-0.07	0.87	0.89	0.94	0.92	-0.62	0.85	0.54	0.84	0.88	0.64	0.82	-0.45		0.73	0.91	0.72	0.7	0.75	0.89	0.91	0.9	-0.88	-0.84
Non Current Liabilities Total	0.92	-0.55	-0.55	0.95	0.86	0.85	0.7	-0.66	0.5	0.94	0.69	0.93	0.96	0.66	-0.62	0.73		0.58	0.97	0.7	0.98	0.91	0.59	0.67	-0.82	-0.86
Inventory	0.76	0.01	0.03	0.75	0.79	0.87	0.91	-0.56	0.97	0.32	0.83	0.75	0.41	0.83	-0.25	0.91	0.58		0.51	0.47	0.67	0.78	0.98	0.93	-0.76	-0.67
Other Current Assets	0.94	-0.62	-0.46	0.95	0.88	0.85	0.7	-0.68	0.46	0.95	0.7	0.94	0.99	0.66	-0.67	0.72	0.97	0.51		0.79	0.94	0.92	0.54	0.65	-0.78	-0.84
Other Stockholder Equity	0.83	-0.81	0.13	0.8	0.86	0.8	0.74	-0.9	0.51	0.59	0.83	0.83	0.72	0.81	-0.92	0.7	0.7	0.47	0.79		0.74	0.84	0.56	0.73	-0.84	-0.86
Total Liab	0.95	-0.53	-0.4	0.96	0.92	0.9	0.79	-0.77	0.62	0.85	0.8	0.95	0.9	0.79	-0.67	0.75	0.98	0.67	0.94	0.74		0.94	0.69	0.78	-0.86	-0.87
Total Current Assets	1.0	-0.5	-0.2	0.99	0.99	0.98	0.91	-0.8	0.76	0.77	0.9	1.0	0.86	0.88	-0.67	0.89	0.91	0.78	0.92	0.84	0.94		0.81	0.89	-0.9	-0.9
Short Term Debt	0.8	-0.06	0.11	0.77	0.84	0.9	0.92	-0.65	0.98	0.32	0.89	0.78	0.44	0.89	-0.36	0.91	0.59	0.98	0.54	0.56	0.69	0.81		0.96	-0.78	-0.69
Intangible Assets	0.87	-0.3	0.15	0.84	0.92	0.95	0.98	-0.82	0.95	0.41	0.98	0.86	0.54	0.98	-0.57	0.9	0.67	0.93	0.65	0.73	0.78	0.89	0.96		-0.88	-0.8
Common Stock	-0.89	0.62	0.05	-0.88	-0.9	-0.9	-0.9	0.85	-0.71	-0.61	-0.89	-0.89	-0.71	-0.87	0.76	-0.88	-0.82	-0.76	-0.78	-0.84	-0.86	-0.9	-0.78	-0.88		0.99
Common Stock Shares Outstanding	-0.89	0.7	0.16	-0.89	-0.88	-0.87	-0.84	0.83	-0.6	-0.7	-0.82	-0.89	-0.78	-0.81	0.79	-0.84	-0.86	-0.67	-0.84	-0.86	-0.87	-0.9	-0.69	-0.8	0.99

Click cells to compare fundamentals

CAMP4 THERAPEUTICS Account Relationship Matchups

CAMP4 THERAPEUTICS fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	433.8M	391.6M	380.1M	54.9M	49.5M	47.0M
Other Current Liab	(1.5M)	(1.9M)	(25.1M)	694K	624.6K	655.8K
Total Current Liabilities	107.2M	90.5M	106.5M	7.8M	7.0M	6.7M
Total Stockholder Equity	95.1M	75.4M	14.3M	(123.7M)	(111.4M)	(105.8M)
Property Plant And Equipment Net	55.4M	50.0M	45.1M	13.3M	12.0M	11.4M
Retained Earnings	(138.0M)	(166.0M)	(168.8M)	(160.0M)	(144.0M)	(151.2M)
Accounts Payable	35.8M	31.8M	52.7M	1.0M	937.8K	890.9K
Cash	94.6M	79.2M	41.9M	38.4M	34.5M	57.8M
Non Current Assets Total	219.5M	210.2M	205.3M	14.9M	13.4M	12.8M
Non Currrent Assets Other	27.2M	29.6M	36.1M	1.6M	1.5M	1.4M
Non Current Liabilities Total	231.5M	225.7M	259.3M	170.9M	153.8M	179.8M
Other Current Assets	24.8M	22.3M	26.0M	319K	287.1K	272.7K
Total Liab	338.7M	316.2M	365.8M	178.7M	160.8M	249.2M
Total Current Assets	214.3M	181.4M	174.8M	40.0M	36.0M	34.2M

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CAMP4 Total Liab vs Other Stockholder Equity Analysis

Total Liab vs Other Stockholder Equity

Total Liab vs Other Stockholder Equity Correlation Analysis

Correlation Coefficient

Total Liab

Other Stockholder Equity

CAMP4 THERAPEUTICS fundamental ratios Correlations

CAMP4 THERAPEUTICS Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CAMP4 THERAPEUTICS fundamental ratios Accounts

Additional Tools for CAMP4 Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Non Current Assets Total

Other Stockholder Equity	- 0.92	Net Receivables
Cash And Short Term Investments	- 0.92	Net Debt
Cash	- 0.91	Net Debt
Common Stock Shares Outstanding	- 0.9	Total Current Assets
Common Stock	- 0.9	Total Current Assets
Other Stockholder Equity	- 0.9	Net Debt